Verrica (VRCA) news

Recent news

Verrica Pharmaceuticals - Topline data from Cove-2 expected in Q1 2027

Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) reported second-quarter 2026 financial results and business updates, highlighting continued growth in its flagship product, YCANTH, and progress in its clinical pipeline. The company noted that dispensed applicator units for YCANTH reached 19,626 in Q2…

AInvest Wire · 4d ago

Verrica Pharmaceuticals shares rise 12% after partner reports trial results

AInvest Wire · Dec 15, 2023

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by